Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab • May 30, 2020
Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease. Diabetes Obes Metab • January 15, 2019
Glycaemic Efficacy and Safety of Linagliptin compared to Basal-Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non-Cardiac Surgery: A Multicenter Randomized Clinical Trial. Diabetes Obes Metab • November 21, 2018
Hypoglycemia in Hospitalized Patients with or without Heart Failure. Diabetes Obes Metab • May 29, 2018
Dapagliflozin for prednisone-induced hyperglycemia in acute exacerbation of chronic obstructive pulmonary disease. Diabetes Obes Metab • January 10, 2018
Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study. Diabetes Obes Metab • November 3, 2017
The use of U-500 regular insulin in the management of patients with obesity and insulin resistance. Diabetes Obes Metab • May 20, 2014
Glucose control in non-critically ill inpatients with diabetes: towards closed-loop. Diabetes Obes Metab • November 26, 2013
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab • November 6, 2013